Inhibikase Therapeutics, Inc. (IKT)

Inhibikase Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	77.74	56.49	9.17	7.19	40.75	13.95
Short-Term Investments	9.92	41.05	4.09	15.86	-	-
Cash & Short-Term Investments	87.67	97.54	13.25	23.05	40.75	13.95
Cash Growth	1004.10%	636.06%	-42.51%	-43.44%	192.04%	75500.11%
Receivables	-	-	-	0.04	0.11	-
Prepaid Expenses	0.68	0.8	0.74	0.16	1.5	0.05
Other Current Assets	0.45	0.11	0.22	1.12	0.11	0.77
Total Current Assets	88.79	98.45	14.21	24.37	42.47	14.78
Property, Plant & Equipment	0.06	0.15	0.3	0.57	-	-
Total Assets	88.85	98.6	14.51	24.94	42.47	14.78
Accounts Payable	2.7	0.94	0.65	1.15	1.09	1.72
Accrued Expenses	3.15	2.68	2.26	2.4	2.72	0.63
Short-Term Debt	-	-	0.38	-	-	0.04
Current Portion of Long-Term Debt	-	-	-	-	0.25	-
Current Portion of Leases	0.04	0.11	0.15	0.15	-	-
Current Unearned Revenue	-	-	-	-	-	2.33
Total Current Liabilities	8.8	3.73	3.44	3.7	4.05	4.72
Long-Term Debt	-	-	-	-	-	0.28
Long-Term Leases	-	-	0.09	0.21	-	-
Total Liabilities	8.8	3.73	3.53	3.9	4.05	5
Common Stock	0.07	0.07	0.01	0	0.03	0.01
Additional Paid-In Capital	198	189.25	77.87	68.8	68.21	24.81
Retained Earnings	-118.01	-94.42	-66.9	-47.87	-29.82	-15.03
Comprehensive Income & Other	-0	-0.04	0	0.1	-	-
Shareholders' Equity	80.05	94.87	10.98	21.04	38.42	9.78
Total Liabilities & Equity	88.85	98.6	14.51	24.94	42.47	14.78
Total Debt	0.04	0.11	0.62	0.35	0.25	0.32
Net Cash (Debt)	87.63	97.43	12.63	22.7	40.5	13.63
Net Cash Growth	1055.29%	671.44%	-44.36%	-43.95%	197.05%	-
Net Cash Per Share	1.35	4.11	2.10	5.37	13.35	9.96
Filing Date Shares Outstanding	74.52	74.34	6.48	4.83	4.2	1.68
Total Common Shares Outstanding	74.52	69.36	6.19	4.2	4.19	1.68
Working Capital	80	94.72	10.77	20.68	38.42	10.06
Book Value Per Share	1.07	1.37	1.77	5.00	9.16	5.84
Tangible Book Value	80.05	94.87	10.98	21.04	38.42	9.78
Tangible Book Value Per Share	1.07	1.37	1.77	5.00	9.16	5.84
Machinery	-	0.1	0.1	0.24	-	-

Updated May 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q